Anthem, Inc. (ANTM)
Dopo ore:
| Chiusura precedente | 505,29 |
| Aperto | 504,42 |
| Denaro | 0,00 x 800 |
| Lettera | 521,68 x 1000 |
| Min-Max giorno | 500,30 - 510,99 |
| Intervallo di 52 settimane | 355,43 - 533,68 |
| Volume | |
| Media Volume | 1.221.940 |
| Capitalizzazione | 121,695B |
| Beta (5 anni mensile) | 0,97 |
| Rapporto PE (ttm) | 19,87 |
| EPS (ttm) | 25,40 |
| Prossima data utili | 19 lug 2022 - 25 lug 2022 |
| Rendimento e dividendo (forward) | 5,12 (1,03%) |
| Data ex dividendo | 09 giu 2022 |
| Stima target 1A | 569,85 |
- FX Empire
Anthem Shares Hit Record High After A Blowout Quarter
“Anthem (ANTM) reported a clean EPS and MLR beat, which should further serve to alleviate the fear-trade surrounding managed care medical cost trend. Normalized segment results further reinforce commercial cost pressure vs government cost weakness,” noted Gary Taylor, equity analyst at Cowen.
- GlobeNewswire
Treace Medical Concepts Appoints New Directors
PONTE VEDRA, Fla., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus (commonly known as bunions), today announced the appointment of Betsy Hanna and Deepti Jain to its Board of Directors effective October 1, 2021. “With decades of combined experience in healthcare leadership, Ms. Hanna and Ms. Jain strengthen the exp
